BSL_EP044

BSL_EP044 is a **plant extract formulation** studied in clinical trials for its potential effect on glycemic metabolism, specifically in women diagnosed with polycystic ovary syndrome (PCOS)[3]. The compound is described as a plant extract, though the specific botanical source and exact composition are not disclosed in public sources. Its primary indication is for improving glycemic metabolism, with most evidence focusing on its use in PCOS. The mechanism of action is not described in detail in the available literature, but typically, plant extracts investigated for metabolic effects may act through antioxidant, anti-inflammatory, or insulin-sensitizing pathways. The developer or sponsor for this compound is associated with clinical trial registration, but the exact company is not specified in accessible databases.